Dr. Rubio joined Revance as Senior Vice President of Clinical Development in March of 2016 and currently oversees the Therapeutic and Aesthetic development programs. Prior to Revance, Dr. Rubio served more than 11 years at Genentech, Inc.,ascending through a number of clinical and development management roles to Global Head of Ophthalmology.There he played key leadership roles in the successful development and approval of several ophthalmic indications for Genentech’s Lucentis® (ranibizumab injection).
Dr. Rubio has an MBA in Healthcare Management and Finance from The Wharton School, University of Pennsylvania, and received his Doctor of Medicine from University of California, San Francisco. He currently serves on the Board of the Wharton Health Care Alumni Association and is Chair of the Career Development Committee.
Contact Roman at:
[email protected]